Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.30%75.08B | 8.20%292.18B | 31.29%81B | 8.16%270.04B | 9.89%78.88B | 6.40%66.81B | 2.44%62.66B | 14.38%61.69B | 15.22%249.67B | 26.46%71.78B |
| Cost of revenue | -6.80%46.22B | 4.68%183.66B | 24.00%49.59B | -0.22%175.46B | 2.94%52.28B | -0.77%42.15B | -7.82%41.04B | 5.08%39.99B | 9.52%175.84B | 19.15%50.79B |
| Gross profit | -8.10%28.87B | 14.73%108.52B | 44.73%31.41B | 28.11%94.58B | 26.73%26.6B | 21.38%24.66B | 29.90%21.62B | 36.67%21.7B | 31.53%73.83B | 48.50%20.99B |
| Operating expense | 4.18%17.76B | 7.74%70.7B | 13.70%17.05B | 10.31%65.62B | 14.58%19.01B | 9.86%16.36B | 3.80%15.25B | 12.69%15B | 14.09%59.48B | 23.71%16.59B |
| Operating profit | -22.68%11.11B | 30.57%37.82B | 114.09%14.36B | 101.87%28.97B | 72.61%7.59B | 52.99%8.3B | 225.98%6.37B | 160.54%6.71B | 258.90%14.35B | 510.42%4.4B |
| Net non-operating interest income (expenses) | -35.23%-952M | -15.35%-3.07B | -4.30%-704M | -0.79%-2.66B | 1.07%-650M | 1.03%-672M | -1.68%-667M | -3.69%-675M | -1.61%-2.64B | -5.63%-657M |
| Non-operating interest income | -83.82%11M | -6.53%229M | 38.78%68M | 23.12%245M | 48.94%70M | 57.14%66M | -3.23%60M | 2.08%49M | 255.36%199M | 67.86%47M |
| Non-operating interest expense | 24.74%963M | 13.51%3.3B | 6.63%772M | 2.36%2.91B | 2.27%720M | 2.36%738M | 1.25%727M | 3.58%724M | 6.96%2.84B | 8.31%704M |
| Net investment income | -68.86%284M | -85.36%159M | 19.53%912M | 109.65%1.09B | 548.00%224M | 4.00%-48M | 79.27%147M | 42.35%763M | -10.69%518M | -113.97%-50M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 5,200.00%159M | 5,100.00%156M | 3M | 0 | 0 | 0 | 3M | 0 | 0 |
| Income from associates and other participating interests | 151M | 0 | ||||||||
| Special income (charges) | -4.17%-75M | -104.08%-4.45B | -1,128.57%-72M | -116.39%-2.18B | -273.43%-1.97B | -50.50%-152M | 81.30%-66M | 126.92%7M | -553.60%-1.01B | -401.14%-527M |
| Less:Restructuring and mergern&acquisition | ---- | --1.99B | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 4.17%75M | -85.61%134M | 1,128.57%72M | 63.62%931M | 548.74%772M | 114.08%152M | -96.03%14M | -126.92%-7M | 484.46%569M | 163.30%119M |
| Less:Write off | ---- | 86.46%2.33B | ---- | 184.93%1.25B | 193.14%1.2B | --0 | ---- | ---- | 3,269.23%438M | 3,038.46%408M |
| Other non-operating income (expenses) | -427.87%-200M | 37.76%-244M | 32.61%61M | -176.71%-392M | -352.11%-358M | -78.87%30M | -211.11%-110M | -64.06%46M | -61.11%511M | -48.36%142M |
| Income before tax | -30.93%10.16B | 22.99%30.52B | 114.74%14.72B | 111.60%24.82B | 46.25%4.83B | 57.44%7.46B | 404.00%5.68B | 167.49%6.85B | 220.03%11.73B | 248.52%3.3B |
| Income tax | -32.51%2.81B | -8.44%8.13B | 132.38%4.16B | 85.71%8.88B | 50.47%2.74B | 45.38%2.42B | 182.23%1.92B | 193.13%1.79B | 163.31%4.78B | 279.38%1.82B |
| Net income | -30.30%7.36B | 40.49%22.4B | 108.47%10.55B | 129.38%15.94B | 40.90%2.09B | 64.04%5.04B | 743.37%3.75B | 159.46%5.06B | 275.88%6.95B | 217.77%1.48B |
| Net income continuous operations | -30.31%7.36B | 40.48%22.4B | 108.49%10.55B | 129.40%15.94B | 41.07%2.09B | 63.99%5.04B | 743.37%3.75B | 159.46%5.06B | 275.68%6.95B | 216.88%1.48B |
| Noncontrolling interests | 0 | 92.70%-10M | 163.89%23M | -372.41%-137M | -176.92%-36M | 287.50%30M | -4,650.00%-95M | -1,900.00%-36M | -480.00%-29M | -533.33%-13M |
| Net income attributable to the company | -30.15%7.36B | 39.35%22.41B | 106.53%10.53B | 130.37%16.08B | 42.06%2.13B | 62.18%5.01B | 759.15%3.85B | 161.70%5.1B | 276.28%6.98B | 222.84%1.5B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -30.15%7.36B | 39.35%22.41B | 106.53%10.53B | 130.37%16.08B | 42.06%2.13B | 62.18%5.01B | 759.15%3.85B | 161.70%5.1B | 276.28%6.98B | 222.84%1.5B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -29.00%76.3 | 39.43%228.84 | 106.51%107.4689 | 130.36%164.13 | 42.05%21.72 | 62.19%51.09 | 759.52%39.28 | 161.64%52.04 | 276.19%71.25 | 222.57%15.29 |
| Diluted earnings per share | -29.00%76.3 | 39.43%228.84 | 106.51%107.4689 | 130.36%164.13 | 42.06%21.72 | 62.19%51.0852 | 759.52%39.28 | 161.64%52.04 | 276.19%71.25 | 222.85%15.2895 |
| Dividend per share | 0 | 30.00%65 | 0 | 100.00%50 | 100.00%30 | 0 | 100.00%20 | 0 | 25.00%25 | -25.00%15 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |